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Abstract Pseudoaneurysms after visceral transplantation
represent a significant risk to patients. We report the suc-
cessful treatment of three transplant (pancreas, liver and
kidney) artery anastomotic pseudoaneurysms using physi-
cian-modified fenestrated endovascular stent grafts. In all
cases, surgical repair was considered high risk and would
have compromised the arterial supply to the graft. The
endovascular approach in all cases obviated the need for
surgical intervention and maintained graft arterial supply.
Keywords Anastomotic pseudoaneurysm 
Physician-modified fenestrated stent grafts  Visceral
transplant pseudoaneurysms  Endovascular
pseudoaneurysm repair
Introduction
Pseudoaneurysms of the arterial anastomosis to visceral
transplants are rare. They are more common in pancreas
transplants because of sepsis and damage from pancreatic
leaks with a reported incidence of up to 8% [1]. Their
treatment remains controversial, but includes conservative,
surgical and endovascular options. Open surgical repair is
normally advocated, but more recently, with the evolution
of endovascular practice, a greater variety of management
options are available. Preservation of graft arterial supply is
critical to preserve transplant function. We present three
cases in which physician-modified fenestrated stent grafts
were created and deployed successfully thereby excluding
the pseudoaneurysm from pressurisation and maintaining
graft vessel patency.
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Technique Overview and Case Descriptions
A stent graft for the treatment of a visceral transplant
pseudoaneurysm is an off-label use that requires specific
preoperative consent. Computed tomography (CT) angio-
graphic imaging is essential for planning, and device
modification should take place in a sterile environment. We
recommend that it is done immediately prior to implant, in
the same theatre, to minimise the risk of contamination
through handling. The choice of stent graft device is
pragmatic, determined by local availability and the size of
artery to which the transplant is anastomosed. Thoracic
aortic, abdominal aortic and iliac devices can be used.
The graft design is planned from the CT imaging in a
similar manner to planning a standard complex EVAR.
After a suitable donor stent graft has been identified, the
rotational orientation and the distance from the proximal
edge of the stent graft for the centre point of the fenes-
tration should be measured from multi-planar reconstruc-
tion of the CT scan. 1-mm slices are generally the
maximum slice thickness that we would consider sensible.
The fenestration size is determined by the size of the
transplant vessel and should be roughly equal.
The graft is typically deployed on a sterile field
(Fig. 1A), and the planned site for the fenestration is drawn
with a sterile pen. The simplest way to determine the
rotational position of the fenestration is to convert the angle
to a linear measurement on the circumference of the graft.
With the stent graft temporarily flattened, each side of the
graft represents  of the circumference.
Metal struts from the skeleton of the stent graft should
be avoided, and in most cases it is possible to position a
single fenestration away from the struts; however, in other
more complex designs, we have successfully removed
struts with wire cutters, carefully suturing over the cut
ends.
Existing radiopaque markers are useful to orientate the
graft, and one marker on the proximal edge should be used
to mark either zero degrees or the fenestration angle,
depending on user preference. If no markers are correctly
positioned, they can be removed and re-sutured onto a
more useful position.
Polyester donor stent grafts can be easily shortened with
an Accutemp low-temperature cautery pen (Beaver Visitec
International, Waltham, MA, USA). This pen is also used
to create the fenestration (Fig. 1B). The fenestration is then
reinforced with a gold gooseneck snare loop cut from the
wire shaft (Fig. 1C). We have used either 7 mm or 10 mm
microsnares (EV3 (Medtronic), Dublin Ireland). The
10-mm snare has better fluoroscopic visibility and can be
reduced in size as needed. At least 5 mm of the snare shaft
should be left attached to prevent the snare from
unravelling. The snare is sutured in place around the cus-
tom fenestration using 5/0 PTFE sutures (Gore & Associ-
ates, Newark, Delaware, USA) (Fig. 1D). The modified
device is then re-packaged into the delivery system. This is
aided by the use of a valve stent crimper (Edwards Life-
sciences, California, USA) (Fig. 1E) but is not essential.
Alternative methods include wrapping a spiral of heavy
suture or tape around the graft and unwrapping the suture
as the graft is recovered by the delivery system outer sheath
by an assistant. Great care should be taken to avoid graft
twist. Finally the graft can be soaked in Rifampin to reduce
the chance of infection [2].
Deployment is similar to a standard fenestrated EVAR.
Accurate positioning of the fenestration during initial
deployment is the key, particularly as there is only limited
ability to move the main stent graft when it is uncovered.
We recommend visualising the ostium of the target
(transplant) artery in the two orthogonal planes which can
be determined from the CT scan. The fenestration should
be positioned adjacent to the target vessel, but the goose-
neck snare is always deformed within the delivery system
and does not give a reliable indication of rotational align-
ment, so the radio-opaque markers on the proximal edge of
the stent graft should be used to finesse the rotation as the
graft is initially uncovered. It can be helpful to position a
catheter or guidewire within the target vessel to aid
alignment.
Once the main graft is deployed, the fenestration should
be catheterised from within the graft in a standard manner.
A guidewire is passed into target vessel, followed by a long
vascular sheath. An appropriate balloon mounted covered
stent (e.g. Atrium Advanta V12) (Maquet, Rastatt Ger-
many), sized to the transplant artery, is then deployed
across the fenestration into the target vessel. The covered
stent is over-dilated, typically to 8 to 12 mm within the
fenestration to seal the fenestration and prevent migration.
The technique described herein was used in three
transplant cases: pancreas, liver and kidney (summarised in
Table 1). In all cases, surgical repair was considered high
risk and could have compromised the arterial supply to the
graft; therefore, endovascular management was preferred.
Discussion
Visceral transplant anastomotic pseudoaneurysm formation
is rare but a life- and transplant organ-threatening com-
plication. They have a multi-factorial aetiology including
surgical technique, infection, post-operative anasto-
motic/bile leak and pancreatitis [3, 4]. Clinical presentation
is also highly variable ranging from asymptomatic (de-
tected on routine imagine follow up) to life threatening
(acute rupture) [5, 6]. Transplant hepatic artery
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pseudoaneurysm formation is estimated to occur in
0.27–3% of cases [5, 7–12]. The treatment of transplant
pseudoaneurysms remains controversial, and due to its
infrequent occurrence, there is a paucity of published lit-
erature to support a definitive management approach,
where possible, open surgical revision of the anastomosis
would normally be considered the first-line treatment.
However, this often results in loss of the transplant.
Transplant artery ligation is another management approach
that has been suggested but again usually has the same
outcome with gradual graft loss [6].
Endovascular management can be considered an alter-
native to open surgery in the management of transplant
arterial pseudoaneurysms; however, its technical validity
has been questioned [12]. Global experience remains lim-
ited with evidence restricted to case reports or small series.
The location of transplant pseudoaneurysms is critical
when considering an endovascular approach. For
Fig. 1 A Partial deployment of
a stent graft in a sterile
environment with marks drawn
for the planned fenestration
(arrow). B Accutemp low-
temperature cautery pen (arrow
head) used to create the
fenestration (black arrow), with
a segment of the stent graft
removed (white arrow).
C Gooseneck snare (arrow) used
to reinforce the fenestration.
D The snare has been sutured in
place around the custom
fenestration using PTFE sutures.
E A valve stent crimper is used
to re-package the stent graft into
the delivery system
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pseudoaneurysms of the transplant artery itself away from
the anastomosis, stent grafting has been shown to be a
successful technique [13–18]. However, when a transplant
artery pseudoaneurysm involves the anastomosis or ostium,
standard stent grafting is of limited value because it would
involve sacrificing/covering the transplant vessel origin
thereby risking the graft. In order to preserve flow into a
transplant artery whilst excluding the pseudoaneurysm
from blood flow, this requires stent grafting in a T con-
figuration using a fenestration to preserve the graft vessel.
There is no off-the-shelf, commercially available
endovascular device designed for this purpose. Endovas-
cular options are therefore limited to commercially made
custom grafts or physician modification of existing off-the-
shelf equipment. As commercially made custom endovas-
cular stent grafts typically take 2–4 months to manufacture,
this is not normally a suitable option to manage the
emergent nature of transplant pseudoaneurysms.
The use of physician-modified fenestrated stent grafts
has been described in the emergent treatment of complex
aortic aneurysms with favourable clinical outcomes
[19–22]. This served as a rationale for using this technique
in the treatment of the transplant pseudoaneurysms pre-
sented in this series. An alternative endovascular approach
that has been described in the context of an anastomotic
pseudoaneurysm in a renal transplant is parallel grafting
Table 1 Case summaries
Case Gender Age Transplant Pseudoaneurysm details Procedure Follow-up
1 Male 46 Pancreas as part
of
simultaneous
pancreas and
kidney (SPK
transplant)
14 mm wide necked (8 mm)
pseudoaneurysm arising from
the right common iliac artery
at the origin of the Y graft
arterial conduit (Fig. 2)
Medtronic Endurant
13 mm 9 80 mm stent graft
limb extension (ETEW 13 13
c 80 EE) was shortened to
50 mm
Single fenestration measuring
6 mm was created and
reinforced with a 7-mm
microsnare tip cut from the
wire shaft, and sutured in
place with 5/0 PTFE. Radio-
opaque markers salvaged from
the discarded portion of the
stent graft were reattached
with 7/0 prolene
Fenestration catheterised
(Fig. 3) and stented with
8 mm 9 18 mm lifestream
(Bard, Georgia, USA) balloon
expandable covered stent
flared to 10 mm
11 month follow up CT showed
a preserved graft pancreatic
artery supply with complete
involution of the
pseudoaneurysm (Fig. 4)
2 Male 37 Liver 5-cm saccular pseudoaneurysm
at the origin of the hepatic
arterial conduit
7-mm fenestration was created
in a Medtronic Endurant stent
graft cuff (ETCF 28 28 c 50
EE)
Reinforced with a 10-mm
gooseneck snare (reduced to
7 mm diameter) and sutured
with 5/0 PTFE
Atrium Advanta V12 covered
stent (5 9 38 mm) deployed
through the fenestration and
flared to 10 mm
Migration of covered stent
resulting in pseudoaneurysm
expansion at 1 month with a
presumed type III endoleak.
A further 5 9 38 mm V12
stent was deployed and flared
to 12 mm. CT at 2 weeks
confirmed pseudoaneurysm
exclusion and ultrasound at
6 weeks demonstrated
preserved arterial supply to
the liver
3 Male 45 Kidney Anastomotic pseudoaneurysm
compressing the transplant
renal artery (Fig. 5),
markedly reducing flow
Single fenestration was created
in a Medtronic Endurant stent
graft limb and reinforced with
a 7-mm microsnare then
sutured with 4/0 PTFE.
Fenestration catheterised and
stented with an Atrium
Advanta V12 covered stent
Received 6-month dual
antiplatelet therapy
(Clopidogrel and Aspirin).
Pseudoaneurysm successfully
excluded with no recurrence
at 12-month follow-up
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[23]. This involves two stent grafts deployed side by side,
one into the transplant artery and one extending across the
vessel origin. While this can exclude a pseudoaneurysm, it
is a comparatively less attractive option as blood can
continue to flow in the gutters between the stents thereby
allowing continued perfusion to the pseudoaneurysm. The
relative diameters and lengths of the involved vessels are
important in determining suitability for parallel grafting.
None of the presented cases were suitable for parallel
grafting.
The aetiology of pseudoaneurysm formation in the cases
described remains uncertain, but endovascular manage-
ment has obviated the need for surgery thus far and
maintained graft vascular supply. Some of these pseudoa-
neurysms developed in the presence of infection. This can
be considered a contra-indication to endovascular repair,
but there are reports of successful endovascular stent
grafting in the presence of infection, either as a bridge to
definitive open repair or as a definitive solution itself
[24–26]. In the first case, infection was considered possi-
ble, but no clinical or micro-biological evidence was found.
The patient remains well without antibiotics. The second
case is perhaps more contentious. There is a significant
possibility that the anastomotic failure was due to local
fungal infection. The patient remains on anti-fungal ther-
apy, and it is recognised that there is a significant possi-
bility that further surgery will be required. However,
neither the local transplant nor vascular surgeons felt that
Fig. 2 3D reconstructed CT demonstrating a 14-mm pseudoa-
neurysm (arrow) arising from the right common iliac artery at the
origin of the Y graft arterial conduit
Fig. 3 Physician-modified fenestrated stent graft deployed in the
right common iliac artery. Fenestration catheterised with guidewire in
the pancreatic transplant artery. Atrium V12 balloon mounted stent in
place and ready to be deployed
Fig. 4 Contrast enhanced CT at 11 months demonstrating a patent
graft pancreatic artery and involution of the pseudoaneurysm
Fig. 5 Iliac angiogram demonstrating a pseudoaneurysm (black
arrow) arising from the transplant renal artery anastomosis. Also
present (not shown) was a tight proximal renal artery stenosis
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open repair of the pseudoaneurysm would be possible
without loss of the arterial supply to the transplant liver and
the recipient may still require a third liver transplant. In the
third case, infection may have been the cause given the
positive urine cultures for Klebsiella. The patient did
receive treatment with Aztreonam/Dapsone and neverthe-
less remains well with a functioning renal transplant.
Conclusion
Transplant pseudoaneurysms are a difficult to manage and
high-risk patient group. The cases presented here using
physician-modified fenestrated stent grafts successfully
treated the pseudoaneurysms and maintained graft vascular
supply. This technique is technically demanding but
promising. Longer-term follow-up is needed to better
understand this technique’s true clinical value.
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